Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHornby Regulatory News (HRN)

  • There is currently no data for HRN

Trading Statement

22 Apr 2024 07:00

RNS Number : 3956L
Hornby PLC
22 April 2024
 

Hornby Plc ("Hornby" or "the Group")

Trading Update

Hornby Plc, the international models and collectibles Group, is today updating shareholders on trading for its 4th quarter and the year ended 31 March 2024.

Business Performance 

Group sales for the 4th quarter were 8% less than the same period last year due to Easter falling earlier, Red Sea delivery delays and the resultant movement of some high value containers into April instead of March.

Therefore, Group sales for the financial year ended 31 March 2024 were £56.2 million, only marginally ahead of the prior year at 2%. Margins are slightly behind due to higher tooling amortisation than in prior years, although we have seen a modest improvement in margins in the second half of the year.

The Group's direct-to-consumer sales continue to increase strongly, at 18% ahead of last year, and our overall performance continues on the positive growth trajectory of recent years.

Our underlying loss before tax has weakened since the half-year point. Nonetheless, this still represents a slight improvement in H2 profitability compared to the previous year, despite facing higher interest rate charges on borrowings and increased tooling amortisation from prior year's tooling purchases now in production. The result for the year is in line with our expectations.

Financial Position

Net debt as at 31 March 2024 was £14.3 million compared to net debt of £5.5 million at the end of March 2023 mainly due to the trading loss and capital expenditure. This does, however, show a slight improvement from £14.6M at the half year. Stock has reduced by 12%, or £3 million, since the half year, and is slightly lower than March 2023.

Outlook

Whilst we close the year in a loss-making position and both net debt and inventory are still too high, we have seen a marked change in trajectory since the half year and aim to continue this positive improvement throughout the current financial year.

We have invested in new Sales and Marketing teams, along with adding Research, Data and Loyalty capabilities, which we expect to start improving our revenue and margins positively this financial year through the identification of new customers, opening up of new territories and launch of new product ranges.

We do, however, remain cautious in our outlook due to the natural challenges facing a business in turnaround, and the uncertainty of the wider economic and socio-political factors affecting all businesses at this time.

Hornby will announce its preliminary results for the year ended 31 March 2024 in June.

Enquiries:

Hornby PLC

Olly Raeburn, CEO 01843 233 500

Kirstie Gould, CFO

Holly Barnett, PR

 

Liberum Capital Limited, Nominated Advisor and Broker

Andrew Godber 020 3100 2222

Edward Thomas

Anake Singh

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKZGMDKLVGDZM
Date   Source Headline
19th Oct 200910:35 amRNSDirector Declaration
13th Oct 20094:35 pmRNSPrice Monitoring Extension
7th Oct 20097:00 amRNSNotice of Results
6th Aug 20094:40 pmRNSSecond Price Monitoring Extn
6th Aug 20094:35 pmRNSPrice Monitoring Extension
30th Jul 20097:00 amRNSAGM Statement and Interim Management Statement
21st Jul 20097:00 amRNSLicence Win
23rd Jun 20099:23 amRNSDirector/PDMR Shareholding
23rd Jun 20097:51 amRNSDirector/PDMR Shareholding
5th Jun 20097:00 amRNSFinal Results
22nd Apr 20093:35 pmRNSHolding(s) in Company
20th Apr 20093:51 pmRNSHolding(s) in Company
31st Mar 20097:04 amRNSPre-Close Trading Update & Change of Adviser
30th Mar 20099:54 amRNSHolding(s) in Company
6th Mar 20094:35 pmRNSPrice Monitoring Extension
27th Jan 20097:00 amRNSTrading Statement
22nd Jan 20099:45 amRNSHolding(s) in Company
19th Dec 20084:37 pmRNSPrice Monitoring Extension
28th Nov 20084:40 pmRNSSecond Price Monitoring Extn
28th Nov 20084:36 pmRNSPrice Monitoring Extension
7th Nov 20087:00 amRNSInterim Results
27th Oct 20089:22 amRNSAdditional Listing
23rd Oct 20084:49 pmRNSHolding(s) in Company
23rd Oct 20084:41 pmRNSHolding(s) in Company
23rd Oct 20084:37 pmRNSHolding(s) in Company
23rd Oct 20081:28 pmRNSNotice of Results
21st Oct 200811:14 amRNSAdditional Listing
15th Oct 200811:21 amRNSAdditional Listing
25th Sep 20085:43 pmRNSHolding(s) in Company
18th Aug 20082:39 pmRNSHolding(s) in Company
1st Aug 20082:21 pmRNSDirector/PDMR Shareholding
28th Jul 200812:00 pmRNSAGM Statement
24th Jun 20083:27 pmRNSDirector/PDMR Shareholding
6th Jun 20087:00 amRNSFinal Results
14th May 200812:01 pmRNSNotice of Results
1st May 20087:01 amRNSAcquisition
29th Apr 20082:56 pmRNSDirector Declaration
22nd Apr 20089:23 amRNSHolding(s) in Company
31st Mar 20087:00 amRNSTrading Statement
25th Mar 20088:51 amRNSHolding(s) in Company
3rd Mar 200810:34 amRNSHolding(s) in Company
6th Feb 200811:53 amRNSDirector/PDMR Shareholding
31st Jan 200812:05 pmRNSHolding(s) in Company
29th Jan 20083:51 pmRNSHolding(s) in Company
29th Jan 200810:10 amRNSDirector/PDMR Shareholding
28th Jan 20087:00 amRNSTrading Statement
3rd Dec 20074:46 pmRNSDirector/PDMR Shareholding
27th Nov 20072:26 pmRNSDirector/PDMR Shareholding
23rd Nov 20077:00 amRNSDirectorate Change
21st Nov 20079:46 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.